Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiromasa Kitamura

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
CEN Case Reports|October 23, 2019
A case of ischemic osteopathy in a hemodialysis patient with advanced peripheral artery diseaseShunsuke Yamada, Toshiaki Nakano, Hiromasa Kitamura, et al.
Clinical and Experimental Nephrology|May 4, 2022
Prevalence, treatment status, and predictors of anemia and erythropoietin hyporesponsiveness in Japanese patients with non-dialysis-dependent chronic kidney disease: a cross-sectional studyShigeru Tanaka, Hiromasa Kitamura, Kazuhiko Tsuruya, et al.
Journal of Atherosclerosis and Thrombosis|April 17, 2024
Impact of Age on Prescribing Patterns of Cardiovascular Medications in Older Japanese Patients with Non-Dialysis-Dependent Chronic Kidney Disease: A Cross-Sectional StudyShigeru Tanaka, Hiromasa Kitamura, Kazuhiko Tsuruya, et al.
American Journal of Nephrology|January 8, 2025
Associations of Causes of Chronic Kidney Disease with Disease Progression and Mortality: Insights from the Fukuoka Kidney Disease Registry StudyHiromasa Kitamura, Shigeru Tanaka, Hiroto Hiyamuta, et al.
Clinical and Experimental Nephrology|September 13, 2022
Association between hyporesponsiveness to erythropoiesis-stimulating agents and risk of brain hemorrhage in patients undergoing hemodialysis: the Q-Cohort StudyYushi Uchida, Toshiaki Nakano, Hiromasa Kitamura, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 27, 2024
Estimated potassium intake and the progression of chronic kidney diseaseTatsuya Suenaga, Shigeru Tanaka, Hiromasa Kitamura, et al.
Clinical and Experimental Nephrology|August 4, 2022
Current antihypertensive treatment and treatment-resistant hypertension in Japanese patients with chronic kidney diseaseAkihiro Tsuchimoto, Shigeru Tanaka, Hiromasa Kitamura, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 11, 2024
Vascular Calcification Is Accelerated by Hyponatremia and Low OsmolalityShumei Matsueda, Shunsuke Yamada, Kumiko Torisu, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 26, 2025
Association between the urinary sodium-to-potassium ratio and apparent treatment-resistant hypertension in Japanese patients with non-dialysis dependent chronic kidney disease: the Fukuoka Kidney disease Registry studyYuta Matsukuma, Shigeru Tanaka, Masaru Nakayama, et al.
Journal of Atherosclerosis and Thrombosis|January 3, 2023
Cardiovascular Risk Factor Burden and Treatment Control in Patients with Chronic Kidney Disease: A Cross-Sectional StudyHiromasa Kitamura, Shigeru Tanaka, Hiroto Hiyamuta, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
CEN Case Reports|October 23, 2019
A case of ischemic osteopathy in a hemodialysis patient with advanced peripheral artery diseaseShunsuke Yamada, Toshiaki Nakano, Hiromasa Kitamura, et al.
Clinical and Experimental Nephrology|May 4, 2022
Prevalence, treatment status, and predictors of anemia and erythropoietin hyporesponsiveness in Japanese patients with non-dialysis-dependent chronic kidney disease: a cross-sectional studyShigeru Tanaka, Hiromasa Kitamura, Kazuhiko Tsuruya, et al.
Journal of Atherosclerosis and Thrombosis|April 17, 2024
Impact of Age on Prescribing Patterns of Cardiovascular Medications in Older Japanese Patients with Non-Dialysis-Dependent Chronic Kidney Disease: A Cross-Sectional StudyShigeru Tanaka, Hiromasa Kitamura, Kazuhiko Tsuruya, et al.
American Journal of Nephrology|January 8, 2025
Associations of Causes of Chronic Kidney Disease with Disease Progression and Mortality: Insights from the Fukuoka Kidney Disease Registry StudyHiromasa Kitamura, Shigeru Tanaka, Hiroto Hiyamuta, et al.
Clinical and Experimental Nephrology|September 13, 2022
Association between hyporesponsiveness to erythropoiesis-stimulating agents and risk of brain hemorrhage in patients undergoing hemodialysis: the Q-Cohort StudyYushi Uchida, Toshiaki Nakano, Hiromasa Kitamura, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 27, 2024
Estimated potassium intake and the progression of chronic kidney diseaseTatsuya Suenaga, Shigeru Tanaka, Hiromasa Kitamura, et al.
Clinical and Experimental Nephrology|August 4, 2022
Current antihypertensive treatment and treatment-resistant hypertension in Japanese patients with chronic kidney diseaseAkihiro Tsuchimoto, Shigeru Tanaka, Hiromasa Kitamura, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 11, 2024
Vascular Calcification Is Accelerated by Hyponatremia and Low OsmolalityShumei Matsueda, Shunsuke Yamada, Kumiko Torisu, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 26, 2025
Association between the urinary sodium-to-potassium ratio and apparent treatment-resistant hypertension in Japanese patients with non-dialysis dependent chronic kidney disease: the Fukuoka Kidney disease Registry studyYuta Matsukuma, Shigeru Tanaka, Masaru Nakayama, et al.
Journal of Atherosclerosis and Thrombosis|January 3, 2023
Cardiovascular Risk Factor Burden and Treatment Control in Patients with Chronic Kidney Disease: A Cross-Sectional StudyHiromasa Kitamura, Shigeru Tanaka, Hiroto Hiyamuta, et al.
Pageof 3